Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Models for Drug Testing: Organoids & Tissue Chips 2022

3D-Models for Drug Testing: Organoids & Tissue Chips 2022



Conference Chairman

Albert Folch

Albert Folch
Professor of Bioengineering, University of Washington

Plenary Speakers

Nancy Allbritton

Nancy Allbritton
Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington in Seattle

Danilo Tagle

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Daniel Chiu

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

Keynote Speakers


Cole DeForest
Weyerhaeuser Endowed Professor , University of Washington


Steven C. George
Edward Teller Distinguished Professor and Chair, Department of Biomedical Engineering, University of California-Davis


Noo Li Jeon
Professor, Seoul National University


John Rogers
Simpson/Querrey Professor of Materials Science and Engineering, Northwestern University


Elisabeth Verpoorte
Chair of Analytical Chemistry and Pharmaceutical Analysis, University of Groningen


Matthias von Herrath
Vice President and Senior Medical Officer, Novo Nordisk, Professor, La Jolla Institute

Overview

SelectBIO is pleased to welcome you all to the 3D-Models for Drug Testing: Organoids and Tissue Chips 2022 to be held on-site in-person live in beautiful downtown Seattle.

This conference is held co-located and concurrently with the SelectBIO Extracellular Vesicles 2022 Conference.  All attendees receive full access to both tracks and the networking opportunities during the Food & Beverage events.

This 3D-Models: Organoids and Tissue Chips 2022 Conference focuses on the emerging tools for the ex vivo recapitulation of organ systems on-board microfluidic chips and their utility for modeling physiological and disease processes in a controlled environment. Additionally, technologies and tools for fabricating such systems ex vivo including organoids and tissue chips will be addressed during the conference.

There is a co-located exhibition with companies from around the world exhibiting on-site in person at the conference -- the focus therefore is on presentations from academic and industry speakers and exhibits by the companies offering tools, technologies and services to the field.

**Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event.  Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event. Masks required onsite for all participants.**

Agenda Topics

  • Bioprinting using Microfluidics-based Approaches
  • Building Organoids from Various Tissue Classes (Brain, Gut, Lung, etc.) and Studies on these Organoids
  • Emerging Technologies for Reproducible Production of Organoids
  • Organ-on-a-Chip/Body-on-a-Chip Assembly using Microfluidics: Tools and Approaches
  • Spheroids -- 3D Aggregates of Cells in Culture: Technologies and Applications
  • Tissue-on-a-Chip Applications for Drug Discovery and Toxicity Screening

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Mehdi Nikkhah, Associate Professor of Bioengineering, Arizona State University
Rebecca Pompano, Associate Professor, Carter Immunology Center, University of Virginia
Ying Zheng, Associate Professor, Department of Bioengineering, University of Washington
Kelly Stevens, Associate Professor, Department of Bioengineering, University of Washington
Christopher Easley, C. Harry Knowles Professor, Auburn University
Ali Khademhosseini, CEO and Founding Director, Terasaki Institute for Biomedical Innovation
Jeffrey Borenstein, Group Leader, Synthetic Biology; Director, Biomedical Engineering Center, Draper
Brian O'Grady, Post-Doctoral Researcher, Vanderbilt University
Thomas Gervais, Professor of Engineering Physics and Biomedical Engineering, Ecole Polytechnique de Montréal
Viraj Mehta, Research Fellow, Indian Institute of Technology, Hyderabad
Yen-Ting Tung, Research Fellow, 3D Tissue Bioprinting Group, National Center for Advancing Translational Sciences (NCATS)


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks